Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Solid Tumor 3Lung Neoplasms 3Breast Neoplasms 3Glioma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Oncologic Diseases 1Neurotoxicity Syndromes 1Melanoma 1Liver Cirrhosis 1Glioblastoma 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Watchful Waiting 2Psychiatric Rehabilitation 2Immunohistochemistry 2Biopsy 2Amplified Fragment Length Polymorphism Analysis 2ribociclib 1palbociclib 1abemaciclib 1X-Ray Therapy 1Therapeutics 1Radiotherapy 1Radiosurgery 1Phlebotomy 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Immunoenzyme Techniques 1High-Energy Shock Waves 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Blood Specimen Collection 1Biopsy, Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Neoplasms, Male × Fluorodeoxyglucose F18 × Clear all
NCT00362973 2016-12-28

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

University of Washington

Completed
42 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡